Phase I trial of intravenous WX 554 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2010
At a glance
- Drugs WX 554 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 17 Jun 2010 Status changed to completed, based on information presented in a WILEX media release.
- 07 May 2010 New trial record